Table 1 (abstract P137).
Univariate comparison of the characteristics of patients with ≤4 headache days per month (super responders) vs patients who had a decrease <30% in headache days per month (non-responders)
| Super responders (n=27) |
Non-responders (n=40) |
P value | OR | |
|---|---|---|---|---|
| Age, median (IQR) | 54.4 (53-56) | 47 (45-54) | 0.638 | - |
| Female sex, n (%) | 21 (77.6) | 37 (92.5) | 0.083 | 0.52 (0.20-1.34) |
| Migraine years, median (IQR) | 44.5 (38-51) | 27 (23-45) | 0.144 | - |
| Chronic migraine duration (months), median (IQR) | 8.5 (5-12) | 120 (24-120) | 0.056 | - |
| Monthly headache days, median (IQR) | 30 (23.5-30) | 30 (25-30) | 0.146 | - |
| Medication overuse, n (%) | 17 (63.0) | 33 (84.6) | 0.044 | 1.84 (1.07-3.16) |
| Allodynia, n (%) | 10 (41.7) | 16 (47.1) | 0.684 | 0.91 (0.59-1.41) |
| Unilateral headache, n (%) | 12 (44.4) | 16 (41.0) | 0.782 | 1.06 (0.70-1.60) |
| Throbbing headache, n (%) | 18 (66.7) | 21 (53.8) | 0.298 | 1.24 (0.84-1.84) |
| Baseline MIDAS score, median (IQR) | 106.5 (81-132) | 92 (41-203) | 0.923 | - |
| Baseline HIT-6 score, median (IQR) | 77 (72-82) | 71 (64-72) | 0.154 | - |
| Baseline VAS score, median (IQR) | 9.5 (9-10) | 10 (8-10) | 0.301 | - |
| Baseline BDI score, median (IQR) | 33.5 (30-37) | 9 (6-21) | 0.051 | - |
| Baseline GAD-7 score, median (IQR) | 19 (14-24) | 4 (3-12) | 0.051 | - |